Anticancer drugs: Breaking up a pro-survival interaction

Nature Reviews Cancer 16, 754 (2016). doi:10.1038/nrc.2016.139 Author: Alexandra Flemming A paper in Nature describes a highly specific and potent small molecule inhibitor of MCL1 that has single-agent activity and good tolerability in several cancer models.
Source: Nature Reviews Cancer - Category: Cancer & Oncology Authors: Tags: Research Highlight Source Type: research